Tag: Phase 2 clinical study
October 8, 2019
Novan’s Phase 2 SB206 Study Published in Journal of American Academy of Dermatology
The company's results from its Phase 2 SB206 trial were published in the Journal of the American Academy of Dermatology. September 18, 2019
vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study
The study evaluated patients with type 1 diabetes and was presented at the Meeting of the European Association for the... June 13, 2019
Progenics Pharmaceuticals Doses First Patient in Phase 2 Clinical Study of 1095 Radiotherapy
Progenics Pharmaceuticals (NASDAQ:PGNX) has announced the first patient in its Phase 2 clinical trial studying I-131 1095 radiotherapy has been... January 16, 2019
Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
Aptinyx (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced... May 10, 2018
Aptevo Therapeutics Reports First Quarter 2018 Financial Results
Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today provided a business review and... April 27, 2018
Cytokinetics Reports First Quarter 2018 Financial Results
Cytokinetics (Nasdaq:CYTK) reported financial results for the first quarter of 2018. Net loss for the first quarter was $30.3 million,...
April 19, 2018